X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4878) 4878
neurosciences (3593) 3593
parkinson's disease (3216) 3216
humans (3105) 3105
male (2424) 2424
dopaminergic-neurons (2300) 2300
mice (1945) 1945
neurons (1816) 1816
dopamine (1747) 1747
rats (1673) 1673
parkinsons-disease (1637) 1637
disease models, animal (1547) 1547
parkinson disease - pathology (1324) 1324
oxidative stress (1311) 1311
neurology (1301) 1301
neurodegeneration (1279) 1279
dopaminergic neurons - metabolism (1258) 1258
substantia-nigra (1183) 1183
brain (1167) 1167
female (1161) 1161
dopaminergic neurons - pathology (1135) 1135
parkinson’s disease (1130) 1130
alpha-synuclein (1075) 1075
dopamine - metabolism (1071) 1071
neurodegenerative diseases (1058) 1058
cell biology (1019) 1019
biochemistry & molecular biology (1003) 1003
nervous system (993) 993
parkinson disease - metabolism (991) 991
mice, inbred c57bl (961) 961
dopaminergic neurons - drug effects (937) 937
analysis (922) 922
movement disorders (878) 878
clinical neurology (837) 837
substantia nigra - pathology (795) 795
rats, sprague-dawley (786) 786
parkinsons disease (756) 756
substantia nigra (747) 747
tyrosine 3-monooxygenase - metabolism (739) 739
neurons - metabolism (721) 721
apoptosis (716) 716
neuroprotection (683) 683
substantia nigra - metabolism (676) 676
dopamine receptors (666) 666
parkinson disease - genetics (629) 629
pharmacology & pharmacy (622) 622
research (619) 619
rodents (612) 612
neurons - pathology (603) 603
proteins (592) 592
cells, cultured (589) 589
mptp (574) 574
nervous system diseases (570) 570
neurons - drug effects (564) 564
neurotoxicity (547) 547
expression (542) 542
immunohistochemistry (535) 535
neuroprotective agents - pharmacology (535) 535
biomedicine (525) 525
multidisciplinary sciences (520) 520
inflammation (519) 519
mouse model (516) 516
brain - pathology (505) 505
substantia nigra - drug effects (504) 504
disease (503) 503
physiological aspects (498) 498
alzheimers-disease (490) 490
degeneration (486) 486
parkinson disease - physiopathology (478) 478
microglia (475) 475
dopaminergic neurons (473) 473
brain - metabolism (464) 464
alpha-synuclein - metabolism (459) 459
gene expression (456) 456
basal ganglia (453) 453
mitochondria (451) 451
pathology (451) 451
parkinson disease - drug therapy (444) 444
neuroscience (438) 438
medicine (437) 437
mutation (433) 433
corpus striatum - pathology (431) 431
cell-death (429) 429
in-vivo (421) 421
health aspects (420) 420
corpus striatum - metabolism (419) 419
parkinson disease (417) 417
rats, wistar (415) 415
research article (415) 415
stem cells (415) 415
neurotrophic factor (397) 397
animal models (394) 394
parkinsonian disorders - pathology (394) 394
aged (373) 373
in-vitro (372) 372
cell death (370) 370
middle aged (355) 355
mice, knockout (354) 354
neuroinflammation (353) 353
activation (350) 350
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6770) 6770
Japanese (26) 26
Russian (12) 12
Spanish (12) 12
French (7) 7
German (6) 6
Chinese (5) 5
Portuguese (3) 3
Dutch (2) 2
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 2008, Volume 119, Issue 1, pp. 182 - 192
Journal Article
The Journal of neuroscience, ISSN 0270-6474, 07/2016, Volume 36, Issue 29, pp. 7693 - 7706
Journal Article
The Journal of clinical investigation, ISSN 1558-8238, 2019, Volume 129, Issue 9, pp. 3738 - 3753
Journal Article
Molecular brain, ISSN 1756-6606, 2012, Volume 5, Issue 1, pp. 35 - 35
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2018, Volume 115, Issue 41, pp. 10481 - 10486
Journal Article
Cell stem cell, ISSN 1934-5909, 2011, Volume 8, Issue 3, pp. 267 - 280
Studies of Parkinson's disease (PD) have been hindered by lack of access to affected human dopaminergic (DA) neurons... 
PLURIPOTENT STEM-CELLS | KINASE-ACTIVITY | ALZHEIMERS-DISEASE | ANIMAL-MODELS | HUMAN FIBROBLASTS | ALPHA-SYNUCLEIN | LEWY-BODY-DISEASE | SUBSTANTIA-NIGRA | MIDBRAIN DOPAMINERGIC-NEURONS | PARKINSONS-DISEASE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Neurons - pathology | Humans | Middle Aged | rho-Associated Kinases - antagonists & inhibitors | Amino Acid Substitution - drug effects | Oxidopamine - pharmacology | rho-Associated Kinases - metabolism | Female | Cell Death - drug effects | Neurons - drug effects | Dopamine - metabolism | Protein-Serine-Threonine Kinases - metabolism | Induced Pluripotent Stem Cells - metabolism | Mesencephalon - pathology | Amides - pharmacology | Induced Pluripotent Stem Cells - pathology | Parkinson Disease - pathology | Induced Pluripotent Stem Cells - drug effects | Hydrogen Peroxide - pharmacology | Protein-Serine-Threonine Kinases - genetics | Parkinson Disease - genetics | Mutation - genetics | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Leupeptins - pharmacology | Phenotype | Animals | Cell Differentiation - drug effects | Parkinson Disease - enzymology | Mice | Pyridines - pharmacology | Oxidative Stress - drug effects | α-synuclein(SNCA) | 6-hydroxydopamine | p.G2019S | hydrogen peroxide | Leucine Rich Repeat Kinase 2 (LRRK2) | human embryonic stem cells (hESCs) | induced pluripotent stem cells (iPSCs) | midbrain dopaminergic neurons (mDA) | Parkinson’s disease | MG-132
Journal Article
Neuropsychopharmacology (New York, N.Y.), ISSN 1740-634X, 2013, Volume 39, Issue 5, pp. 1066 - 1080
Methamphetamine is a widely abused illicit drug. Recent epidemiological studies showed that methamphetamine increases the risk for developing Parkinson's... 
silver-degeneration stain | neurotoxicity | Parkinson's disease | psychostimulants | cell death | amphetamine derivatives | MOUSE STRIATUM | PSYCHIATRY | D-1 | SUBSTANTIA-NIGRA | NEUROSCIENCES | STRIATAL DOPAMINE | NEURONS | PHARMACOLOGY & PHARMACY | MICE | RECEPTORS | BRAIN | PARKINSONS-DISEASE | Immunohistochemistry | Motor Activity - physiology | Neurons - pathology | Tyrosine 3-Monooxygenase - metabolism | Neural Pathways - drug effects | Substantia Nigra - pathology | Apoptosis - drug effects | Dopaminergic Neurons - pathology | Motor Activity - drug effects | Male | Neural Pathways - pathology | Substantia Nigra - metabolism | Corpus Striatum - metabolism | Necrosis - pathology | Nerve Degeneration - chemically induced | Nerve Degeneration - metabolism | Dose-Response Relationship, Drug | Dopamine Agents - pharmacology | Dopaminergic Neurons - metabolism | Dopaminergic Neurons - drug effects | Neurons - metabolism | Neurons - drug effects | Corpus Striatum - pathology | Methamphetamine - pharmacology | Mice, Inbred C57BL | Silver Staining | Axons - drug effects | Axons - metabolism | Mice, Transgenic | Necrosis - metabolism | Nerve Degeneration - pathology | Necrosis - chemically induced | Substantia Nigra - drug effects | Animals | Axons - pathology | Corpus Striatum - drug effects | Neural Pathways - metabolism | Mice | Apoptosis - physiology | Index Medicus | Neuroprotection | Addiction & Substance Abuse | Dopamine | Neurodegeneration | Parkinson's Disease | Movement Disorders | Original
Journal Article